巴菲特追随者Eoysne
巴菲特追随者Eoysne
Profile:头顶三尺思盈利,探索利益新路子!专注研究趋势、前景和未来!
91Follow
143Followers
0Topic
0Badge
$Vaxart, Inc(VXRT)$Press Release DetailsVaxart Announces FDA Clearance of IND Application for Oral ** Vaccine and Provides Update on ** ProgramSeptember 14, 2020 at 8:00 AM EDTPDF VersionRecruitment for Phase 1 clinical study expected to start this monthData from ongoing hamster challenge study expected in OctoberSOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral ** vaccine candidate. The Company also provi

Go to Tiger App to see more news